Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes.

MLA

Montesanto, Alberto, et al. “Erythropoietin (EPO) Haplotype Associated with All-Cause Mortality in a Cohort of Italian Patients with Type-2 Diabetes.” Scientific Reports, vol. 9, no. 1, July 2019, p. 10395. EBSCOhost, https://doi.org/10.1038/s41598-019-46894-2.

APA

Montesanto, A., Bonfigli, A. R., De Luca, M., Crocco, P., Garagnani, P., Marasco, E., Pirazzini, C., Giuliani, C., Romagnoli, F., Franceschi, C., Passarino, G., Testa, R., Olivieri, F., & Rose, G. (2019). Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes. Scientific Reports, 9(1), 10395. https://doi.org/10.1038/s41598-019-46894-2

Chicago

Montesanto, Alberto, Anna Rita Bonfigli, Maria De Luca, Paolina Crocco, Paolo Garagnani, Elena Marasco, Chiara Pirazzini, et al. 2019. “Erythropoietin (EPO) Haplotype Associated with All-Cause Mortality in a Cohort of Italian Patients with Type-2 Diabetes.” Scientific Reports 9 (1): 10395. doi:10.1038/s41598-019-46894-2.